Özdemir, A. Et Al. 2021. Omalizumab in chronic urticaria; real-life data of 6-year-experience. Turkish Journal of Dermatology , vol.15, no.3 , 66-73.

Özdemir, A., Bilgiç, A., Koyuncu, M. A., & Yılmaz, E., (2021). Omalizumab in chronic urticaria; real-life data of 6-year-experience. Turkish Journal of Dermatology , vol.15, no.3, 66-73.

Özdemir, ADEM Et Al. "Omalizumab in chronic urticaria; real-life data of 6-year-experience," Turkish Journal of Dermatology , vol.15, no.3, 66-73, 2021

Özdemir, ADEM Et Al. "Omalizumab in chronic urticaria; real-life data of 6-year-experience." Turkish Journal of Dermatology , vol.15, no.3, pp.66-73, 2021

Özdemir, A. Et Al. (2021) . "Omalizumab in chronic urticaria; real-life data of 6-year-experience." Turkish Journal of Dermatology , vol.15, no.3, pp.66-73.

@article{article, author={ADEM ÖZDEMİR Et Al. }, title={Omalizumab in chronic urticaria; real-life data of 6-year-experience}, journal={Turkish Journal of Dermatology}, year=2021, pages={66-73} }